Cargando…
Activation of ADRB2/PKA Signaling Pathway Facilitates Lipid Synthesis in Meibocytes, and Beta-Blocker Glaucoma Drug Impedes PKA-Induced Lipid Synthesis by Inhibiting ADRB2
Meibomian gland dysfunction is one of the main causes of dry eye disease and has limited therapeutic options. In this study, we investigated the biological function of the beta 2-adrenergic receptor (ADRB2)/protein kinase A (PKA) pathway in lipid synthesis and its underlying mechanisms in human meib...
Autores principales: | Jun, Ikhyun, Choi, Young Joon, Kim, Bo-Rahm, Seo, Kyoung Yul, Kim, Tae-im |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409328/ https://www.ncbi.nlm.nih.gov/pubmed/36012741 http://dx.doi.org/10.3390/ijms23169478 |
Ejemplares similares
-
Genetic Polymorphisms in ADRB2 and ADRB1 Are Associated with Differential Survival in Heart Failure Patients Taking β-Blockers
por: Guerra, Leonardo A., et al.
Publicado: (2022) -
PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disorders
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2018) -
ADRB2-Targeting Therapies for Prostate Cancer
por: Kulik, George
Publicado: (2019) -
Human-Specific SNP in Obesity Genes, Adrenergic Receptor Beta2 (ADRB2), Beta3 (ADRB3), and PPAR γ2 (PPARG), during Primate Evolution
por: Takenaka, Akiko, et al.
Publicado: (2012) -
Association of ADRB2 polymorphism with triglyceride levels in Tongans
por: Naka, Izumi, et al.
Publicado: (2013)